CLS
Celestica Inc.
CLS's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CLS overall, supported by stronger valuation and stronger fundamentals.
CLS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Strong |
CLS's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $115 | -55% |
| Forward | 14x | $254 | — |
| Fair | 17x | $184 | -28% |
| Current | 24x | $254 | — |
| Expensive | 39x | $411 | +62% |
Historical ranges are pointers, not guarantees.
CLS's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CLS in the historical PE scenario, which offers more potential upside but is not a forecast.
CLS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
CLS has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $17.88 | +70% |
| Q3 2026 | $10.55 | +75% |
| Q2 2026 | $9.60 | +114% |
| Q1 2026 | $8.25 | +138% |
| Q4 2025 | $7.16 | +105% |
| Q3 2025 | $6.03 | +98% |
| Q2 2025 | $4.49 | +53% |
| Q1 2025 | $3.47 | +33% |
| Q4 2024 | $3.50 | +72% |
CLS's earnings per share have climbed steadily: $10.55 over the past year, up 75% from the year before, and higher year over year for 23 quarters in a row.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CLS on earnings, with stronger typical year-over-year growth.
CLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.8B | +83% |
| Q2 2026 | $4.7B | +62% |
| Q1 2026 | $4B | +53% |
| Q4 2025 | $3.7B | +44% |
| Q3 2025 | $3.2B | +28% |
| Q2 2025 | $2.9B | +21% |
| Q1 2025 | $2.6B | +20% |
| Q4 2024 | $2.5B | +19% |
CLS's revenue has grown year over year for 20 quarters in a row: $5.8B last quarter, up 83% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -2.3 points |
| Q2 2026 | 9.8% | +0.3 points |
| Q1 2026 | 6.7% | +1.9 points |
| Q4 2025 | 8.6% | +0.9 points |
| Q3 2025 | 10% | +4.7 points |
| Q2 2025 | 9.4% | +3.9 points |
| Q1 2025 | 4.9% | -0.8 points |
| Q4 2024 | 7.7% | +2.1 points |
CLS's operating margin was 7.9% last quarter, down 2.3 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CLS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CLS on profitability, with a higher operating margin.
CLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $115.6M | +30% |
| Q2 2026 | $147.1M | +23% |
| Q1 2026 | $126.8M | +35% |
| Q4 2025 | $155.9M | +471% |
| Q3 2025 | $88.9M | -10% |
| Q2 2025 | $119.9M | +91% |
| Q1 2025 | $93.6M | +38% |
| Q4 2024 | $27.3M | -74% |
CLS's free cash flow has been positive every quarter for seven years: $545M over the past year, up 65% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CLS on cash flow, with more consistent year-over-year improvement.
CLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +5.6M shares |
| 1 year | +5.1% | +5.9M shares |
| 3 years | +1.8% | +2.2M shares |
| 5 years | -2.9% | -3.7M shares |
| Available history | -5.2% | -6.7M shares |
CLS has 122M diluted shares, up 5.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $22.6M |
| Q4 2025 | $35.7M |
| Q3 2025 | — |
| Q2 2025 | $40M |
| Q1 2025 | $77.7M |
| Q4 2024 | $25.5M |
CLS spent $58M buying back its own shares over the past year, down 59% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CLS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.5x | Very low |
CLS has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.2 | Neutral |
| Stochastic | 15.5 | Oversold |
CLS's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CLS PE vs Technology Sector
| Metric | CLS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 14% below |
| PE % | 64 | 35 | 29 pts above |
CLS is trading at 24x earnings, a 14% discount to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CLS on valuation relative to its sector.
CLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $300.6 | 15% below |
| 20 week MA | $313.9 | 19% below |
| 50 week MA | $321.3 | 21% below |
| 100 week MA | $243.1 | 4.5% above |
| 200 week MA | $139.6 | 82% above |
CLS has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.11 | $7.71 | -4.9% |
| 2021 | $7.71 | $10.9 | +41% |
| 2022 | $10.9 | $10.9 | -0.2% |
| 2023 | $10.9 | $29.3 | +170% |
| 2024 | $29.3 | $95.1 | +225% |
| 2025 | $95.1 | $303.6 | +219% |
| 2026 YTD | $303.6 | $254.0 | -16% |
CLS has finished higher in four of the last six years, three of them by more than 50%. It's down 16% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CLS on returns for 2026, with the stronger performance.